Advertisement
Canada markets closed
  • S&P/TSX

    21,947.41
    +124.19 (+0.57%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CAD/USD

    0.7308
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • Bitcoin CAD

    86,629.73
    +687.48 (+0.80%)
     
  • CMC Crypto 200

    1,317.25
    +40.27 (+3.15%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • RUSSELL 2000

    2,035.72
    +19.61 (+0.97%)
     
  • 10-Yr Bond

    4.5000
    -0.0710 (-1.55%)
     
  • NASDAQ

    16,156.33
    +315.37 (+1.99%)
     
  • VOLATILITY

    13.49
    -1.19 (-8.11%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6787
    -0.0030 (-0.44%)
     

KLA-Tencor (KLAC) to Post Q4 Earnings: What's in the Cards?

KLA-Tencor Corporation KLAC is set to report fourth-quarter fiscal 2019 results on Aug 5.

The company topped the Zacks Consensus Estimate in the trailing four quarters, with average of 9.23%.

KLA-Tencor delivered a positive earnings surprise of 10.43% in the last reported quarter. Fiscal third-quarter earnings of $1.80 per share surged 325% year over year.

Strong Product Portfolio — Key Catalyst

KLA-Tencor’s robust product portfolio has been catering to the increasing demand for wafer products, which is a positive for the to-be-reported quarter. The company is expected to witness improved end-market results, especially in China.

ADVERTISEMENT

The addition of new capacity by wafer manufacturers bodes well for the quarter to be reported, given increasing demand for its new wafer products. KLA-Tencor’s efforts in bringing EUV lithography technology to the market via collaborating with every EUV customer are expected to aid the company in the fiscal fourth quarter.

 

KLA-Tencor Corporation Price and EPS Surprise

 

KLA-Tencor Corporation Price and EPS Surprise
KLA-Tencor Corporation Price and EPS Surprise

KLA-Tencor Corporation price-eps-surprise | KLA-Tencor Corporation Quote

Forecasts

For the fiscal fourth quarter, the company expects revenues in the range of $1.21-$1.29 billion. Non-GAAP earnings are expected in the range of $1.55-$1.85 per share.

KLA-Tencor expects shipments within $1.235-$1.315 billion. Memory is expected to be approximately 47% of shipments in the fiscal fourth quarter. Foundry and Logic are expected to constitute around 41% and 12% of its total shipments, respectively, in the quarter.

Reduction in memory capacity investment due to weakness in mobile demand and a lull in data center might impact shipments. Additionally, weakness in China could be an overhang for the to-be-reported quarter.

What Our Model Says

According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or 5) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Earnings ESP: KLA-Tencor has an Earnings ESP of 0.00%.

Zacks Rank: It currently carries a Zacks Rank #3.

This combination makes surprise prediction difficult this earnings season.

Stocks That Warrant a Look

Here are a few stocks worth considering, as our model shows that these have the right combination of elements to deliver an earnings beat in the upcoming releases.

SeaWorld Entertainment SEAS has an Earnings ESP of +11.01% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Cisco Systems Inc. CSCO has an Earnings ESP of +1.53% and a Zacks Rank #2.

Ciena CIEN has an Earnings ESP of +5.26% and a Zacks Rank #2.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cisco Systems, Inc. (CSCO) : Free Stock Analysis Report
 
Ciena Corporation (CIEN) : Free Stock Analysis Report
 
SeaWorld Entertainment, Inc. (SEAS) : Free Stock Analysis Report
 
KLA-Tencor Corporation (KLAC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research